Trump loyalies were wrong about MMWR; Peak global cases; JAK inhibitor wins on COVID test

Please note that some links may require registration or subscription.

White House appointees to the Department of Health and Human Services attempted to amend the CDC’s weekly morbidity and mortality report, scientists’ findings contradicted the president’s positive messages about COVID-19. (Politico)

As of 8:00 a. m. EDT on Monday, unofficial U. S. unemployment recorded 6,520,606 cases and 194,084 deaths, an average of around 36,000 and 800 consistent with the day, respectively, during the week after.

And the World Health Organization (WHO) has reported a record increase in coronavirus infections in one day: about 308,000 new cases in 24 hours, with India, the United States and Brazil reporting the largest accumulations (BBC).

H. Holden Thorp, PhD, editor-in-chief of Science, bit his words in the name of his editorial: “Trump lied about science. “

If you are the governor of Florida, Ron DeSantis (right), the planes are not “vectors” of COVID-19. This is what epidemiologists think. (Kaiser Health News)

Speaking of Florida: partly due to excessively long delays in testing, attempts to find contacts in the state are a “hot disaster” (WTSP).

Eli Lilly stated that his JAK inhibitor, baricitinib (Olumiant), tested in the NIAID ACTT-2 trial as a COVID-19 therapy, showed modest benefits in hospitalized patients.

After being “voluntarily suspended,” the AstraZeneca-Oxford vaccine trial resumes in Britain, the company said.

Not to be left behind, Pfizer and BioNTech reported that they expanded the number of participants in their Phase III trial from 30,000 to 44,000 (STAT).

But some corporations of vaccine experts deserve to be more transparent about how vaccine trials (New York Times) are conducted.

Air pollutants in some counties in Louisiana and New York correlated with disproportionately high rates of COVID-19 (ProPublica) deaths.

The virus also kills others around the world due to increased hunger and food insecurity (New York Times).

In news:

Molly Walker, associate editor-in-chief, covering infectious diseases for MedPage Today, is passionate about evidence, knowledge and public health.

At MedPage Today, we are committed to ensuring that other people with disabilities can access all the content MedPage Today has through our online page and other properties. If you have problems www. medpagetoday. com, MedPageToday mobile apps, please send an email to legal@ziffdavis. com for help. Type “ADA Request” in the thematic line of your email.

Leave a Comment

Your email address will not be published. Required fields are marked *